And Now… Ebola Vaccine Trial

July 28th, 2026

Via: University of Oxford:

The University of Oxford’s Oxford Vaccine Group has today successfully vaccinated the first volunteer in the world’s first clinical trial of a vaccine designed to protect against Bundibugyo ebolavirus (BDBV).

The milestone comes just weeks after the launch of the BD-Ebov study and marks the first time the ChAdOx1 BDBV vaccine has been administered to humans.

The ChAdOx1 BDBV vaccine was developed by scientists at the University of Oxford’s Oxford Vaccine Group and Pandemic Sciences Institute using the same vaccine technology as the Oxford/AstraZeneca COVID-19 vaccine, which is estimated to have saved around six million lives during its first year of use. (sic)

Leave a Reply

You must be logged in to post a comment.